Sam Martin
2021
In 2021, Sam Martin earned a total compensation of $2.5M as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 78% increase compared to previous year.
Compensation breakdown
| Bonus | $205,000 |
|---|---|
| Option Awards | $1,847,535 |
| Salary | $405,303 |
| Other | $9,044 |
| Total | $2,466,882 |
Martin received $1.8M in option awards, accounting for 75% of the total pay in 2021.
Martin also received $205K in bonus, $405.3K in salary and $9K in other compensation.
Rankings
In 2021, Sam Martin's compensation ranked 5,205th out of 12,415 executives tracked by ExecPay. In other words, Martin earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,205 out of 12,415 | 58th |
Division Manufacturing | 2,187 out of 5,505 | 60th |
Major group Chemicals And Allied Products | 947 out of 2,375 | 60th |
Industry group Drugs | 846 out of 2,096 | 60th |
Industry In Vitro and In Vivo Diagnostic Substances | 19 out of 61 | 69th |
Pay ratio
| Sam Martin's Pay | $2,466,882 |
|---|---|
| Median Employee's Pay | $195,006 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Sam Martin was $2,466,882.
The annual total compensation of the median employee at Celldex Therapeutics was $195,006.
The ratio of Sam Martin's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 26, 2022.
Martin's colleagues
We found four more compensation records of executives who worked with Sam Martin at Celldex Therapeutics in 2021.
News
Celldex Therapeutics CEO Anthony Marucci's 2021 pay jumps 101% to $6M
April 26, 2022
Celldex Therapeutics CEO Anthony Marucci's 2020 pay jumps 166% to $3M
April 27, 2021
Celldex Therapeutics CEO Anthony Marucci's 2019 pay slips 19% to $1.1M
April 28, 2020
Celldex Therapeutics CEO Anthony Marucci's 2018 pay slips 17% to $1.4M
April 26, 2019